These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24861153)

  • 1. Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors.
    Leitner GC; Faschingbauer M; Wenda S; Weigel G; Fischer G
    Transfusion; 2014 Dec; 54(12):3121-6. PubMed ID: 24861153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors.
    Shapira MY; Kaspler P; Samuel S; Shoshan S; Or R
    Am J Hematol; 2003 May; 73(1):33-6. PubMed ID: 12701117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
    Gordon SV; Nivison-Smith I; Szer J; Chapman JR
    Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of factors for poor mobilization after administration of recombinant human granulocyte stimulating factor (rHuG-CSF) in healthy donors].
    Aoyama Y; Nakamae H; Yamamura R; Makita K; Shima E; Hasegawa T; Sakamoto C; Kho G; Ohta K; Yamane T; Takubo T; Hino M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):829-36. PubMed ID: 12852351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
    Martino M; Console G; Dattola A; Callea I; Messina G; Moscato T; Massara E; Irrera G; Fedele R; Gervasi A; Bresolin G; Iacopino P
    Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Martino M; Minciullo PL; Saija A; Gangemi S
    Transfus Med; 2005 Oct; 15(5):425-8. PubMed ID: 16202058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
    Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z
    Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors.
    Altehoefer C; Bertz H; Ghanem NA; Langer M
    J Magn Reson Imaging; 2001 Aug; 14(2):141-6. PubMed ID: 11477672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors.
    Kawano Y; Takaue Y; Watanabe T; Abe T; Okamoto Y; Iwai A; Iwai T; Watanabe A; Ito E; Makimoto A; Nakagawa R; Watanabe H; Sato J; Suenaga K; Suzuya H; Ohnishi T; Kanamaru S; Kaneko M; Kuroda Y
    Cancer Res; 1999 Jul; 59(14):3321-4. PubMed ID: 10416586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
    Cella G; Marchetti M; Vignoli A; Randi ML; Saggiorato G; Pasetto L; Pagnan A; Barbui T; Falanga A
    Leukemia; 2006 Aug; 20(8):1430-4. PubMed ID: 16775616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
    Karadogan C; Karadogan I; Bilgin AU; Undar L
    Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.